Markets ▾
Subscribe

BAF NEWS

BAF NEWS

Markets

Latest

Eli Lilly $1 trillion November 2025: What fueled the first pharma to $1 trillion

Eli Lilly $1 trillion November 2025 marks a historic milestone as the company became the first pharmaceutical firm to reach a $1 trillion market value, driven by surging demand for its GLP-1 weight-loss drugs like Mounjaro and Zepbound. The article details the stock's rally, revenue dominance, and competitive landscape, highlighting the significance of this achievement in the pharma sector.
  • No Comments
Nov 20 2025 stock market selloff: Biggest intraday flip since April rattles AI winners
The Nov 20 2025 stock market selloff saw a sharp reversal from morning gains, with volatility spiking and defensives rising as tech and semiconductor stocks slumped. The VIX hit its highest since April, while a delayed jobs report and AI valuation concerns drove risk-off sentiment, impacting global markets.
November 2025 Bitcoin Falls Below $82K: The Big Flush and What Comes Next
This article analyzes the sharp market downturn as november 2025 bitcoin falls below $82k, detailing the rapid selloff, major liquidations, and the broader impact on crypto markets. It covers the timeline from October’s highs to November’s lows, the role of leverage, and the implications for Bitcoin and altcoins moving forward.
Nvidia Q3 2025 earnings: record sales, whipsaw trading, and what’s next
Nvidia Q3 2026 earnings highlighted record revenue of $57.0 billion, with $51.2 billion from data centers, reinforcing Nvidia’s central role in AI infrastructure. The results served as a key indicator for AI spending and market sentiment, while raising questions about customer concentration and chip rental risks.
Treasurer blocks Cosette Mayne Pharma deal as national interest risk trumps takeover
Treasurer blocks Cosette Mayne Pharma deal after accepting FIRB advice that the proposal is not in Australia’s national interest, citing risks to critical medical supply chains and local jobs. The decision triggered a sharp fall in Mayne Pharma shares, a trading halt, and a rescheduled court hearing that will shape future developments.
Nvidia’s Q3 Beat and Bold Guidance Lift Stocks, Temper AI Bubble Fears
Nvidia's Q3 FY26 results and bullish Q4 guidance reignited confidence in AI demand, driving tech stocks and easing bubble concerns. With record data center revenue and strong outlook, markets rewarded Nvidia and peers, highlighting AI infrastructure as a top spending priority for now.
AI Money Floods In. The Risks Are, Too.
The AI investment boom is fueling historic capital flows and innovation, but it's also exposing financial markets to new risks. Aggressive debt issuance, frothy valuations, and concentrated sentiment are amplifying volatility, while regulators intensify oversight. Investors must balance growth optimism with heightened risk management.

Trending in Markets

Stay in the loop